We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Raman Spectroscopy Reveals Tumor Resistance to Radiation

By MedImaging International staff writers
Posted on 27 May 2019
Print article
Image: A new study suggests that Raman spectroscopy can help identify a tumor’s resistance to RT (Photo courtesy of JHU).
Image: A new study suggests that Raman spectroscopy can help identify a tumor’s resistance to RT (Photo courtesy of JHU).
A new study suggests that Raman spectroscopy can identify subtle differences in a tumor’s biochemical environment that correlate with its susceptibility to radiation therapy (RT).

Researchers at Johns Hopkins University (JHU; Baltimore, MD, USA) and the University of Arkansas (UARK; Fayetteville, AR, USA) conducted a murine study to reveal biomolecular changes in tumors induced by radiation, and uncover the latent differences that separate RT-resistant and RT-sensitive tumors. To do so, they grew tumor xenografts in athymic nude mice and quantified the Raman spectroscopic tissue assessments in both untreated and treated tumors by chemometric analysis of the biomolecular differences in the tumor microenvironment.

They found that Raman spectroscopy measurements revealed significant and reliable differences in lipid and collagen content post-radiation in the tumor microenvironment, with consistently greater changes observed in the RT-sensitive tumors. Based on the findings, they then created an algorithm to identify the difference between RT-resistant and nonresistant tumors, and validated it by applying the Raman technique to untreated tumors. The algorithm separated them into RT-sensitive and resistant categories with a success rate of 97%. The study was published on February 28, 2019, in Cancer Research.

“In addition to accurately evaluating tumor response to therapy, the combination of Raman spectral markers potentially offers a route to predicting response in untreated tumors prior to commencing treatment,” concluded lead author Santosh Paidi, MSc, of JHU, and colleagues. “Combined with its non-invasive nature, our findings provide a rationale for in vivo studies using Raman spectroscopy, with the ultimate goal of clinical translation for patient stratification and guiding adaptation of radiotherapy during the course of treatment.”

"This is only the first step of a larger research endeavor to determine how head and neck cancer tumors respond to radiation,” said senior author mechanical engineer Ishan Barman, PhD, of JHU. “The ultimate goal is to build a miniature probe that can fit into a laryngoscope. Hopefully in the future, then, when a clinician performs an endoscopy and looks at a patient's cancerous tumor, they'll be able to determine whether that tumor will even respond to radiation therapy, and that can improve treatment plans.”

Raman spectroscopy is a form of molecular spectroscopy based on Raman scattering. When a beam of light interacts with a material, part of it is transmitted, part it is reflected, and part of it is scattered; over 99% of the scattered radiation has the same frequency as the incident beam, but a small portion of the scattered radiation has frequencies different from that of the incident beam. The scattered radiation contains information on the particular atoms or ions that comprise the molecule, the chemical bonds connect them, the symmetry of their molecule structure, and the physico-chemical environment where they reside.

Related Links:
Johns Hopkins University
University of Arkansas

New
Gold Member
X-Ray QA Meter
T3 AD Pro
Fixed X-Ray System (RAD)
Allengers 325 - 525
Wall Fixtures
MRI SERIES
New
MRI System
Ingenia Prodiva 1.5T CS

Print article

Channels

MRI

view channel
Image: MRI microscopy of mouse and human pancreas with respective histology demonstrating ability of DTI maps to identify pre-malignant lesions (Photo courtesy of Bilreiro C, et al. Investigative Radiology, 2024)

Pioneering MRI Technique Detects Pre-Malignant Pancreatic Lesions for The First Time

Pancreatic cancer is the leading cause of cancer-related fatalities. When the disease is localized, the five-year survival rate is 44%, but once it has spread, the rate drops to around 3%.... Read more

Ultrasound

view channel
Image: A transparent ultrasound transducer-based photoacoustic-ultrasound fusion probe, along with images of a rat’s rectum and a pig’s esophagus (Photo courtesy of POSTECH)

Transparent Ultrasound Transducer for Photoacoustic and Ultrasound Endoscopy to Improve Diagnostic Accuracy

Endoscopic ultrasound is a commonly used tool in gastroenterology for cancer diagnosis; however, it provides limited contrast in soft tissues and only offers structural information, which reduces its diagnostic... Read more

General/Advanced Imaging

view channel
Image: The results of the eight-view 3D CT reconstruction from a public dataset (Photo courtesy of Medical Physics, doi.org/10.1002/mp.12345)

AI Model Reconstructs Sparse-View 3D CT Scan With Much Lower X-Ray Dose

While 3D CT scans provide detailed images of internal structures, the 1,000 to 2,000 X-rays captured from different angles during scanning can increase cancer risk, especially for vulnerable patients.... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.